EUVIMED · CrossrefZeitschrift
Mediterranean Journal of Hematology and Infectious Diseases
ISSN 2035-3006 · Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy
Neueste Artikel
Ten-Year Single-Center Experience in Pediatric Thromboembolism: Management Strategies and Clinical Outcomes
Corrigendum to “Baseline Thrombin Generation Test Does Not Predict Thrombotic Events in Acute Leukemia: A Monocentric Prospective Study”, Mediterr J Hematol Infect Dis 2025; 17(1): e2025076. DOI: 10.4084/MJHID.2025.076
Age-specific seroprevalence and predictors of cytomegalovirus infection in Bosnia and Herzegovina: a 10-year cross-sectional study
RECIPIENT-TO-DONOR ANTI-CMV IGG RATIO AS A PREDICTOR OF CMV REACTIVATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE-CONTROL STUDY
Severe adult protein-energy malnutrition mimicking haematological malignancy: diagnostic lessons from a profound pancytopenia
Acute fulminant Clostridium-Perfrigens sepsis with massive intravascular hemolysis in a young woman with sickle cell disease. Case presentation and review of the literature
ANTIMICROBIAL OPTIMIZATION AFTER POSITIVE PNEUMOCOCCAL URINARY ANTIGEN TESTING IN HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA: A RETROSPECTIVE COHORT STUDY
Pathogen distribution, antimicrobial resistance, and mortality in febrile neutropenia among adults with hematological malignancies: a single-center cohort study
A novel germline JAK2 splice-site variant causing exon 10 skipping in a patient with clinically diagnosed essential thrombocythemia and early-onset tophaceous gout: a case report
TREATMENT OF NEWLY DIAGNOSED POEMS SYNDROME: BORTEZOMIB OR LENALIDOMIDE? EXPERIENCE FROM TWO COUNTRIES
HOW I APPROACH HEMATOLOGIC ABNORMALITIES IN HOSPITALIZED PATIENTS WITH INFECTIOUS DISEASES
OPTIMIZATION OF THE CLINICAL JOURNEY OF UNFIT PATIENTS WITH NEWLY DIAGNOSED IDH1M ACUTE MYELOID LEUKEMIA
MOLECULAR MARKERS IN AML: PROGNOSTIC IMPLICATIONS AND IMPACT ON TREATMENT DECISION-MAKING
ALLOGENEIC TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA IN THE ERA OF NOVEL THERAPIES: CHANGING INDICATIONS AND DYNAMIC RISK ASSESSMENT
NATURAL HISTORY OF GLUCOSE HOMEOSTASIS AND Β-CELL FUNCTION FROM CHILDHOOD TO EARLY ADULTHOOD IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: A NINE-YEAR LONGITUDINAL COHORT STUDY
Dose reduction of ibrutinib in chronic lymphocytic leukemia: long-term outcomes from a real-world single-center experience
MAGNUSIOMYCES CAPITATUS BREAKTHROUGH INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RECEIVING ECHINOCANDIN PROPHYLAXIS: CLINICAL FEATURES, MANAGEMENT, AND REVIEW OF THE LITERATURE
Allogeneic Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis. Two Sides of the Locket: Trigger or Cure?
THE ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS
CLASSICAL HODGKIN LYMPHOMA TODAY
THE IMPACT OF PRE-ANALYTICAL FACTORS ON BLOOD GLUCOSE MEASUREMENTS AND and recommendations THE IMPACT OF PRE-ANALYTICAL FACTORS ON BLOOD GLUCOSE MEASUREMENTS AND RECOMMENDATIONS FOR CLINICAL PRACTICE: AN ICET-A MULTICENTER SURVEY IN TRANSFUSION-DEPENDENT Β THALASSEMIA (Β-TDT) PATIENTS
Atypical evolution of a Vaso-Occlusive presentation in Sickle Cell Disease: lessons in diagnostic vigilance
Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center
EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
ASSOCİATİON BETWEEN IRON OVERLOAD AND GLUCOSE METABOLİSM İN CHİLDREN AND YOUTH WİTH TRANSFUSİON-DEPENDENT BETA THALASSEMİA: THE ROLE OF CHELATİON THERAPY
EVALUATION OF ORAL DOXYCYCLINE, AZITHROMYCIN, OR SEQUENTIAL DOXYCYCLINE-AZITHROMYCIN TREATMENT FOR SCRUB TYPHUS-
LUMBAR PUNCTURE: A CROSS-SECTIONAL STUDY USING THE CHINESE VERSION OF THE STATE ANXIETY SCALE FOR CHILDREN.
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
The Splenectomy Paradox in Thalassemia: Reduced Transfusion Requirements vs. Accelerated Hepatic Fibrogenesis
EUVIMED